$51.84
-5.11-8.97%
At close: Jun 5, 5:00 PM EST
$51.90
0.060.12%
After Hours: Jun 5, 7:41 PM EST
CRISPR Therapeutics AG Earnings Estimates
CRSPNASDAQ
CRISPR Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CRSP
CRISPR Therapeutics (CRSP) is scheduled to report Q2 earnings on August 3, 2026. Analysts estimate EPS of $-1.17 and quarterly revenue of $6.99M.
In the most recent quarter (Q1), CRISPR Therapeutics reported EPS of $-1.28, missing estimates of $-1.22 by 0.05%. Revenue came in at $1.46M, missing the estimate of $5.06M by 0.71%.
CRISPR Therapeutics has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, CRISPR Therapeutics has averaged an EPS surprise of 0.10% and a revenue surprise of 0.81%.
Earnings Date
Aug 3
EPS Estimate
$-1.170
Quarterly Revenue Estimate
$6.99M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$1.00M
CRISPR Therapeutics Earnings History
Analyze the earnings history of CRISPR Therapeutics using advanced sorting and filters.
Loading calendar...
CRISPR Therapeutics (CRSP) Earnings Per Share
The chart below shows CRISPR Therapeutics's reported EPS compared to analyst estimates over recent quarters.
CRISPR Therapeutics (CRSP) Revenue
The chart below shows CRISPR Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?
CRISPR Therapeutics (CRSP) is scheduled to report earnings on August 3, 2026. The last reported earnings were for reported on May 4, 2026 for Q1.
What were the latest earnings per share (EPS) for CRISPR Therapeutics (NASDAQ:CRSP)?
The Actual EPS was $-1.28, which missed the estimate of $-1.22.
What were CRISPR Therapeutics’s (NASDAQ:CRSP) revenues?
The Actual Revenue was $1.46M, which missed the estimate of $5.06M.
